Taylor & Francis Group, a leading publisher of specialist academic books and journals and part of Informa PLC, has acquired the Open Access (OA) publisher, Dove Medical Press. This acquisition signals Taylor & Francis Group’s ongoing commitment to developing both its Medical Journal and OA programs.
Dove Medical Press publishes primarily in the Health Sciences, with additional content in Science and Technology. Since its foundation in 2003, it has steadily built up an attractive portfolio of high quality OA journals including OncoTargets and Therapy (IF 2.612), Clinical Epidemiology (IF 7.056), International Journal of Chronic Obstructive Pulmonary Disease (IF 3.157), International Journal of Nanomedicine (IF 4.3). 86 of the journals are indexed in Clarivate’s Web of Science and 61 in PubMed. A full list is available here: https://www.dovepress.com/browse_journals.php.
Ian Bannerman, Taylor & Francis Journals MD comments, “Taylor & Francis has been purposefully expanding its position in OA over the last few years, to offer the academic community greater flexibility and choice in publishing models. This investment enhances the scale and range of our OA offering to the research community and further enriches the content within our popular Medical program through a range of complementary journals. I am delighted to welcome the Dove Medical Press team, its partners and wider community to our business.”
Philip Smith, Executive Director of Dove Medical Press remarks, “The aim of Dove Medical Press has been to make original, high quality medical and scientific research openly available. Over the last 13 years we have worked with a strong and supportive team of authors and editors to realise this goal. I believe that Taylor & Francis Group shares this vision, and for that reason I am confident they will be a good home to nurture and grow the Dove journal portfolio. I am looking forward to seeing them thrive in their new home.”
The acquisition of Dove is effective immediately. Customers should continue to address queries related to Dove Medical Press directly.
Financial terms have not been disclosed.
About Taylor & Francis Group
Taylor & Francis Group is part of Informa, one of the world’s leading publishers of academic journals. We are dedicated to the dissemination of scholarly information, drawing on expertise developed since first publishing learned journals in 1798. Taylor & Francis now publishes 1,562 scholarly journals in association with over 460 learned societies and scholarly institutions. We operate from a network of 20 global offices, including Philadelphia, Oxford, Melbourne, Stockholm, Beijing, New Delhi, Johannesburg and Singapore.
For more information please contact:
Jennifer McMillan, Head of Communications, Taylor & Francis Group Journals